Pancreatic Cancer: open Trials
ABCSG P02
A prospective randomized phase II trial of FOLFIRINOX alone versus FOLFIRINOX followed by radiochemotherapy in patients with locally advanced, primarily inoperable pancreatic cancer.
ABCSG P02 details »